186 related articles for article (PubMed ID: 32222292)
1. Re: Silke Gillessen, Gerhardt Attard, Tomasz M. Beer, et al. Management of Patients with Advanced Prostate Cancer: Report of the Advanced Prostate Cancer Consensus Conference 2019. Eur Urol. 2020;77: 508-47 https://doi.org/10.1016/j.eururo.2020.01.012.
von Eyben FE; Bauman G; Soydal C; Paganelli G
Eur Urol; 2020 Nov; 78(5):e201-e202. PubMed ID: 32222292
[No Abstract] [Full Text] [Related]
2. Re: Silke Gillessen, Gerhardt Attard, Tomasz M. Beer, et al. Management of Patients with Advanced Prostate Cancer: The Report of the Advanced Prostate Cancer Consensus Conference APCCC 2017. Eur Urol 2018;73:178-211.
von Eyben FE; Virgolini I; Roviello G
Eur Urol; 2018 Feb; 73(2):e31. PubMed ID: 28869068
[No Abstract] [Full Text] [Related]
3. Reply to Finn E. von Eyben, Irene Virgolini and Giandomenico Roviello's Letter to the Editor re: Silke Gillessen, Gerhardt Attard, Tomasz M. Beer, et al. Management of Patients with Advanced Prostate Cancer: The Report of the Advanced Prostate Cancer Consensus Conference APCCC 2017. Eur Urol 2018;73:178-211.
Gillessen S; de Bono JS; Sartor O; Omlin AG
Eur Urol; 2018 Feb; 73(2):e32-e33. PubMed ID: 28869069
[No Abstract] [Full Text] [Related]
4. Re: Jean-Pierre Droz, Gilles Albrand, Silke Gillessen, et al. Management of Prostate Cancer in Elderly Patients: Recommendations of a Task Force of the International Society of Geriatric Oncology. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2016.12.025: Health Assessment of the Elderly is a "Relatively Young" Issue.
Dal Moro F; Motterle G; Barbieri L; Zattoni F
Eur Urol; 2017 May; 71(5):e150-e151. PubMed ID: 28216172
[No Abstract] [Full Text] [Related]
5. Re: Fabio Turco, Andrew Armstrong, Gerhardt Attard, et al. What Experts Think About Prostate Cancer Management During the COVID-19 Pandemic: Report from the Advanced Prostate Cancer Consensus Conference 2021. Eur Urol. 2022;82:6-11.
Wei Y; Zhu Y; Ye D
Eur Urol; 2022 Jul; 82(1):e14. PubMed ID: 35393161
[No Abstract] [Full Text] [Related]
6. Reply to Yu Wei, Yao Zhu, and Dingwei Ye's Letter to the Editor re: Fabio Turco, Andrew Armstrong, Gerhardt Attard, et al. What Experts Think About Prostate Cancer Management During the COVID-19 Pandemic: Report from the Advanced Prostate Cancer Consensus Conference 2021. Eur Urol. 2022;82:6-11.
Turco F; Smith M; Omlin A; Gillessen S
Eur Urol; 2022 Jul; 82(1):e13. PubMed ID: 35469701
[No Abstract] [Full Text] [Related]
7. Re: Karim Fizazi, Charles G. Drake, Tomasz M. Beer, et al. Final Analysis of the Ipilimumab Versus Placebo Following Radiotherapy Phase III Trial in Postdocetaxel Metastatic Castration-resistant Prostate Cancer Identifies an Excess of Long-term Survivors. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2020.07.032: Interpreting the Effect of Ipilimumab Following Radiotherapy for Patients with Postdocetaxel Metastatic Castration-resistant Prostate Cancer.
Ludmir EB; McCaw ZR; Wei LJ
Eur Urol; 2021 Jan; 79(1):e10-e11. PubMed ID: 33109378
[No Abstract] [Full Text] [Related]
8. Reply to Ethan B. Ludmir, Zachary R. McCaw, and Lee-Jen Wei's Letter to the Editor re: Karim Fizazi, Charles G. Drake, Tomasz M. Beer, et al. Final Analysis of the Ipilimumab Versus Placebo Following Radiotherapy Phase III Trial in Postdocetaxel Metastatic Castration-resistant Prostate Cancer Identifies an Excess of Long-term Survivors. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2020.07.032. Interpreting the Effect of Ipilimumab following Radiotherapy for Patients with Postdocetaxel Metastatic Castration-resistant Prostate Cancer.
McHenry MB; Drake CG; Fizazi K
Eur Urol; 2021 Jan; 79(1):e12-e13. PubMed ID: 33121826
[No Abstract] [Full Text] [Related]
9. Re: Yaw A. Nyame, Matthew R. Cooperberg, Marcus G. Cumberbatch, et al. Deconstructing, Addressing, and Eliminating Racial and Ethnic Inequities in Prostate Cancer Care. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2022.03.007.
Wei Y; Ye D; Zhu Y
Eur Urol; 2022 Aug; 82(2):e51. PubMed ID: 35599186
[No Abstract] [Full Text] [Related]
10. Re: Gabriela Ilie, Ricardo Rendon, Ross Mason, et al. A Comprehensive 6-mo Prostate Cancer Patient Empowerment Program Decreases Psychological Distress Among Men Undergoing Curative Prostate Cancer Treatment: A Randomized Clinical Trial. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2023.02.009.
Plata M; Cesar DR; Badillo N
Eur Urol; 2023 Jul; 84(1):e24-e25. PubMed ID: 37147212
[No Abstract] [Full Text] [Related]
11. Re: George J. Netto, Mahul B. Amin, Eva M. Compérat, et al. Prostate Adenocarcinoma Grade Group 1: Rationale for Retaining a Cancer Label in the 2022 World Health Organization Classification. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2022.09.015.
Cimadamore A; Lopez-Beltran A; Cheng L; Montironi R
Eur Urol; 2023 Mar; 83(3):e84-e86. PubMed ID: 36517350
[No Abstract] [Full Text] [Related]
12. Re: Sanoj Punnen, Matthew R. Cooperberg, Anthony V. D'Amico, et al. Management of biochemical recurrence after primary treatment of prostate cancer: a systematic review of the literature. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2013.05.025: Re: Firas Abdollah, Nazareno Suardi, Cesare Cozzarini, et al. Selecting the optimal candidate for adjuvant radiotherapy after radical prostatectomy for prostate cancer: a long-term survival analysis. Eur Urol 2013;63:998-1008.
Parker C; Sydes MR; Kynaston H;
Eur Urol; 2013 Nov; 64(5):e102. PubMed ID: 23953599
[No Abstract] [Full Text] [Related]
13. Re: Joaquin Mateo, Karim Fizazi, Silke Gillessen, et al. Managing Nonmetastatic Castration-resistant Prostate Cancer. Eur Urol 2019:75:285-93.
von Eyben FE; Bauman G
Eur Urol; 2020 Mar; 77(3):e67-e68. PubMed ID: 31300234
[No Abstract] [Full Text] [Related]
14. Re: Joaquin Mateo, Karim Fizazi, Silke Gillessen, et al. Managing Nonmetastatic Castration-resistant Prostate Cancer. Eur Urol 2019;75:285-93.
Rocco B; Sighinolfi MC
Eur Urol; 2020 Mar; 77(3):e69. PubMed ID: 31151677
[No Abstract] [Full Text] [Related]
15. Re: Jeffrey J. Tosoian, Mufaddal Mamawala, Jonathon I. Epstein, et al. Active Surveillance of Grade Group 1 Prostate Cancer: Long-term Outcomes from a Large Prospective Cohort. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2019.12.017.
Froehner M; Koch R; Thomas C
Eur Urol; 2020 Aug; 78(2):e91. PubMed ID: 32381458
[No Abstract] [Full Text] [Related]
16. Re: R. Jeffrey Karnes, Voleak Choeurng, Ashley E. Ross, et al. Validation of a Genomic Risk Classifier to Predict Prostate Cancer-specific Mortality in Men with Adverse Pathologic Features. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2017.03.036.
Ayubi E; Safiri S
Eur Urol; 2017 Dec; 72(6):e157. PubMed ID: 28576506
[No Abstract] [Full Text] [Related]
17. Re: Timothy J. Wilt, Tien N. Vo, Lisa Langsetmo, et al. Radical Prostatectomy or Observation for Clinically Localized Prostate Cancer: Extended Follow-up of the Prostate Cancer Intervention Versus Observation Trial (PIVOT). Eur Urol. In press. https://doi.org/10.1016/j.eururo.2020.02.009.
van den Bergh RCN; Valerio M; Tilki D; Gandaglia G;
Eur Urol; 2020 Aug; 78(2):e67-e68. PubMed ID: 32303383
[No Abstract] [Full Text] [Related]
18. Reply to Mauricio Plata, Cesar Diaz Ritter, and Nicolás Badillo's Letter to the Editor re: Gabriela Ilie, Ricardo Rendon, Ross Mason, et al. A Comprehensive 6-mo Prostate Cancer Patient Empowerment Program Decreases Psychological Distress Among Men Undergoing Curative Prostate Cancer Treatment: A Randomized Clinical Trial. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2023.02.009.
Ilie G; David Harold Rutledge R
Eur Urol; 2023 Jul; 84(1):e26-e27. PubMed ID: 37127468
[No Abstract] [Full Text] [Related]
19. Re: Scott Wilkinson, Huihui Ye, Fatima Karzai, et al. Nascent Prostate Cancer Heterogeneity Drives Evolution and Resistance to Intense Hormonal Therapy. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2021.03.009: Focus on Intraductal Carcinoma of the Prostate.
Cimadamore A; Cheng L; Lopez-Beltran A; Scarpelli M; Montironi R
Eur Urol; 2021 Sep; 80(3):e81-e82. PubMed ID: 34148712
[No Abstract] [Full Text] [Related]
20. Re: Luca F. Valle, Eric J. Lehrer, Daniela Markovic, et al. A Systematic Review and Meta-analysis of Local Salvage Therapies After Radiotherapy for Prostate Cancer (MASTER). Eur Urol. In press. https://doi.org/10.1016/j.eururo.2020.11.010.
Kim SE; Shin JI; Shoag JE
Eur Urol; 2021 Jul; 80(1):e14. PubMed ID: 33941402
[No Abstract] [Full Text] [Related]
[Next] [New Search]
